Marburg Virus News and Research

RSS
Marburg virus or simply Marburg is the common name for the the genus of viruses Marburgvirus, which contains one species, ''Lake Victoria marburgvirus''. The virus causes the disease Marburg Hemorrhagic Fever (MHF), also referred to as ''Marburg Virus Disease''.

Further Reading

New study reveals key part of Ebola virus life cycle at higher resolution than ever before

New study reveals key part of Ebola virus life cycle at higher resolution than ever before

Researchers show how human antibodies can neutralize Marburg virus

Researchers show how human antibodies can neutralize Marburg virus

TSRI scientists show how to target weak spots of Marburg virus with future treatments

TSRI scientists show how to target weak spots of Marburg virus with future treatments

Researchers reveal how human immune system can fight against deadly Marburg virus

Researchers reveal how human immune system can fight against deadly Marburg virus

Study: Airport screening for disease often misses infected travellers, but can be improved

Study: Airport screening for disease often misses infected travellers, but can be improved

Experimental Ebola vaccine safe and immunogenic in African population

Experimental Ebola vaccine safe and immunogenic in African population

New study finds that it is possible to distinguish between different hemorrhagic fevers

New study finds that it is possible to distinguish between different hemorrhagic fevers

Research findings could pave way for new treatments against filoviruses

Research findings could pave way for new treatments against filoviruses

Profectus BioSciences gets funding to develop VesiculoVax Zaire-Ebola virus vaccine

Profectus BioSciences gets funding to develop VesiculoVax Zaire-Ebola virus vaccine

NIAID announces license agreement to develop dual-purpose candidate vaccines for rabies, Ebola

NIAID announces license agreement to develop dual-purpose candidate vaccines for rabies, Ebola

Statement on Ebola epidemic

Statement on Ebola epidemic

Blend of three monoclonal antibodies can protect monkeys against Ebola virus, says UTMB researcher

Blend of three monoclonal antibodies can protect monkeys against Ebola virus, says UTMB researcher

Researchers plan to develop vaccine into a type of antibody serum therapy

Researchers plan to develop vaccine into a type of antibody serum therapy

EcoHealth Alliance examines the origins of Ebola virus outbreaks

EcoHealth Alliance examines the origins of Ebola virus outbreaks

NIH awards $28M grant to establish new center for excellence to find treatment for Ebola virus

NIH awards $28M grant to establish new center for excellence to find treatment for Ebola virus

Researchers Study how Marburg virus and host protein interaction help in developing inhibitors of virus

Researchers Study how Marburg virus and host protein interaction help in developing inhibitors of virus

Small-molecule drug effective in protecting nonhuman primates from lethal Marburg virus

Small-molecule drug effective in protecting nonhuman primates from lethal Marburg virus

Sarepta Therapeutics reports non-GAAP net loss of $29.1 million for Q4 2013

Sarepta Therapeutics reports non-GAAP net loss of $29.1 million for Q4 2013

Sarepta Therapeutics reports positive safety results from AVI-7288 Phase I study

Sarepta Therapeutics reports positive safety results from AVI-7288 Phase I study

BioCryst receives $2.5M to advance development of BCX4430 for Marburg virus disease treatment

BioCryst receives $2.5M to advance development of BCX4430 for Marburg virus disease treatment